Xonvea
Is It Right for You?
A complete guide to Xonvea — what it treats, how it works, dosages, side effects, and when a clinician may prescribe it following an online consultation.
What Is Xonvea?
Xonvea is a prescription-only combination tablet containing two active ingredients: doxylamine succinate (10 mg) and pyridoxine hydrochloride (10 mg). It is specifically licensed in the UK for the treatment of nausea and vomiting of pregnancy (NVP) — commonly known as morning sickness — in women who have not responded adequately to conservative dietary and lifestyle measures.
Doxylamine is a first-generation antihistamine with sedative and antiemetic properties, while pyridoxine is a form of vitamin B6 that plays a key role in nervous system regulation and has established efficacy in reducing pregnancy-related nausea. The combination has a long history of safety and use in pregnancy, with substantial clinical evidence supporting both its effectiveness and its favourable safety profile for mother and baby.
Xonvea is presented as a delayed-release tablet, designed to be taken at night so that its effects are active during the peak nausea period the following morning. It is the only product in the UK specifically formulated and licensed for this combination in pregnancy.
Xonvea is a prescription-only medication in the UK. A licensed clinician must assess your symptoms and obstetric history before it can be prescribed — which can now be done quickly and conveniently through a telehealth consultation.
What Conditions Is Xonvea Used For?
Xonvea is indicated specifically for:
commonly referred to as morning sickness, though symptoms can occur at any time of day. Xonvea is used when dietary and lifestyle modifications alone have not provided adequate relief.
where symptoms are sufficiently disruptive to daily life, work, or nutritional intake to warrant pharmacological treatment
Xonvea is specifically licensed for use in pregnancy. It is not indicated for nausea from other causes such as motion sickness, post-operative nausea, or gastrointestinal illness outside of pregnancy. It should only be used under the supervision of a clinician who has confirmed the diagnosis and assessed suitability.
How Does Xonvea Work?
Xonvea works through two complementary mechanisms:
Doxylamine is a first-generation H1 antihistamine that blocks histamine receptors in the brain — particularly in the vomiting centre (the chemoreceptor trigger zone) and the vestibular system. By blocking these receptors, it reduces the signals that trigger nausea and the vomiting reflex. Doxylamine also has anticholinergic properties, which further suppress the autonomic signals associated with nausea.
Pyridoxine (Vitamin B6) has a well-established but not fully understood role in reducing pregnancy-related nausea. It is thought to modulate neurotransmitter activity, particularly serotonin pathways, and to support normal neurological function in ways that reduce nausea independently of the antihistamine mechanism. Pyridoxine deficiency has been associated with worsening NVP, and supplementation is beneficial even in isolation.
Together, these two agents address nausea through different but complementary pathways, producing a combined effect greater than either component alone. The delayed-release formulation ensures the medication is absorbed during sleep and active during the hours when morning sickness is typically worst.
Dosages & Administration
The correct dose depends on the type and severity of infection, age, weight, and kidney function. Always follow your clinician's instructions. The table below is for general reference only.
Administration Tips
Take Xonvea at bedtime on an empty stomach. The delayed-release formulation is designed for overnight absorption; taking it with food may reduce or delay its effect.
Swallow tablets whole. Do not crush, chew, or split the delayed-release tablets, as this destroys the controlled-release mechanism.
Allow time to work. Xonvea typically requires 2–3 days of consistent use before full benefit is seen. Do not discontinue prematurely if immediate relief is not felt.
Do not drive or operate machinery until you know how Xonvea affects you — doxylamine causes sedation that may persist into the following day, particularly during the first few days of treatment.
Do not take with alcohol or other sedating medications, as this will intensify sedation.
Side Effects of Xonvea
Xonvea is generally well tolerated. Most side effects relate to the sedative properties of doxylamine.
- Drowsiness or somnolence
- Dizziness or light-headedness
- Dry mouth
- Constipation
- Blurred vision
- Fatigue or next-day grogginess
- Severe allergic reaction — hives, facial swelling, difficulty breathing.
Doxylamine causes significant sedation. Patients must not drive or operate machinery until they have established that residual sedation is not impairing their ability to do so safely.
Drug Interactions
Always disclose all prescription drugs, over-the-counter medicines, vitamins, and supplements to your clinician or pharmacist before starting Xonvea. Avoid combining Xonvea with other CNS depressants as it significantly increases sedation and the risk of respiratory depression.
Combining Xonvea with other CNS depressants significantly increases sedation and the risk of respiratory depression. Avoid concurrent use.
Concurrent use with MAOIs is contraindicated. Do not take Xonvea within 14 days of stopping an MAOI due to risk of serious adverse reactions.
Additive anticholinergic effects including urinary retention, dry mouth, constipation, and confusion. Use with caution.
Concurrent use increases sedation and anticholinergic burden. Avoid combining with other antihistamine-containing products.
Important Warnings
Xonvea causes significant drowsiness. Patients must not drive or operate machinery until they have established that residual sedation is not impairing their ability to do so safely. In some patients, next-day drowsiness may be substantial, particularly at higher doses.
Xonvea is specifically designed for use in pregnancy, and the available evidence supports its safety for both mother and baby when used as directed. However, as with all medications in pregnancy, it should be used only when the clinical benefits outweigh any potential risks, and under the supervision of a licensed clinician.
Doxylamine passes into breast milk and may cause sedation in nursing infants. Xonvea is not recommended during breastfeeding. Speak to your clinician about alternative management of nausea if you are breastfeeding.
Xonvea should be used with caution in patients with significant liver or kidney disease. A clinician should assess suitability before prescribing.
Speak to a Clinician About Treatment
Getting advice no longer means sitting in a waiting room. Through The GP Service, you can consult with a licensed clinician in minutes — from home, on your lunch break, or wherever works for you. If treatment is clinically appropriate, your clinician can issue a prescription during the consultation. A consultation does not guarantee a prescription.
The treatment you need, when you need it.
Xonvea FAQs
There is no known dangerous interaction between alcohol and azithromycin. However, alcohol can suppress the immune system and slow recovery from infection. It is generally advisable to limit alcohol consumption while unwell and taking antibiotics.
Hyoscine butylbromide tablets are suitable for children aged 6 years and over. The dose for children aged 6 to 12 is typically 10 mg up to three times daily. It should not be used in children under 6 years. A clinician should assess and prescribe for paediatric use.
Desloratadine is the active metabolite of loratadine – meaning loratadine is converted into desloratadine by the liver after ingestion. Desloratadine works more directly and at a lower dose than loratadine. It also has a slightly longer duration of action. Both are effective, non-sedating antihistamines, but desloratadine is generally considered the more potent of the two.
Most patients begin to notice an improvement in skin or soft tissue infection symptoms – such as reduced redness, swelling, and warmth – within 48 to 72 hours of starting treatment. If symptoms are worsening or not improving after 48 hours, contact your clinician.
Yes. A licensed clinician can evaluate your symptoms via a telehealth consultation and prescribe amoxicillin if clinically appropriate. Prescriptions are typically sent to your preferred pharmacy the same day, often within minutes of your visit.